ログイン
言語:

WEKO3

  • トップ
  • ランキング
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

  1. 50 工学研究科
  2. 学位論文

Process Development for Efficient Production of Antibodies with High Antibody-Dependent Cellular Cytotoxicity Activity from a YB2/0 Cell Line

http://hdl.handle.net/10087/6623
http://hdl.handle.net/10087/6623
6f102bce-39ee-4557-9221-4155ef321a9a
名前 / ファイル ライセンス アクション
Ph.D Ph.D E-428.pdf (4.3 MB)
Item type 学位論文 / Thesis or Dissertation(1)
公開日 2012-02-17
著者 今野, 由信

× 今野, 由信

今野, 由信

Search repository
タイトル
タイトル Process Development for Efficient Production of Antibodies with High Antibody-Dependent Cellular Cytotoxicity Activity from a YB2/0 Cell Line
言語
言語 jpn
その他のタイトル
その他のタイトル 高い細胞傷害活性を有する抗体医薬品のY B 2 / 0 細胞を用いた効率的な物質生産研究
キーワード
主題Scheme Other
主題 Antioxidant
キーワード
主題Scheme Other
主題 CoenzymeQ10
キーワード
主題Scheme Other
主題 Antibody
キーワード
主題Scheme Other
主題 YB2/0
キーワード
主題Scheme Other
主題 CHO
キーワード
主題Scheme Other
主題 Glycosylation
キーワード
主題Scheme Other
主題 Fucosylation
キーワード
主題Scheme Other
主題 Osmolality
キーワード
主題Scheme Other
主題 8-hydroxy-2'-deoxyguanosine
キーワード
主題Scheme Other
主題 Antibody-dependent cellular cytotoxicity
キーワード
主題Scheme Other
主題 ADCC
キーワード
主題Scheme Other
主題 Intracellular calcium level
キーワード
主題Scheme Other
主題 fed-batch
キーワード
主題Scheme Other
主題 perfusion
キーワード
主題Scheme Other
主題 cell culture
資源タイプ
資源タイプ識別子 http://purl.org/coar/resource_type/c_46ec
資源タイプ thesis
著者(ヨミ)
姓名 コンノ, ヨシノブ
著者別名
姓名 Konno, Yoshinobu
抄録
内容記述タイプ Abstract
内容記述 The contribution of biopharmaceutical industries to general healthcare is rapidly increasing\nwith over 165 products having been approved globally since 1982. Within the therapeutic\napplications of biopharmaceuticals, monoclonal antibodies (MAbs) are of growing interest.\nRecently, more than twenty therapeutic MAbs and related proteins have been launched in the\nmarket. This situation is a double-edged sword because it leads to pressure on pharmaceutical\neconomy. Minimizing the cost of goods (COGS) and maximizing antibody activity are therefore\nactive areas of research in the development of MAbs for therapeutic use.\nWe have screened several enhancers of specific MAb production rate (SPR) using the rat\nhybridoma YB2/0 cell line and found that coenzyme-Q10 (CoQ10) is a promising enhancer\ncandidate. CoQ10 is well known as a strong antioxidant in the respiratory chain and is used for\nhealthcare and other applications. Because CoQ10 is negligibly water soluble, most studies are\nlimited by low concentrations. We added CoQ10 to a culture media using dispersion of\nnano-particles (Q-Media) at several concentrations and conducted a fed-batch culture. Although\nthe Q-Media had no effect on cumulative viable cell density, it enhanced the SPR by 66%. In\naddition, the Q-Media had no effect on the binding or cytotoxic activity of MAbs. Q-Media also\nenhanced SPR with CHO and NS0 cell lines by 30%. On the other hand, the Q-Media did not\nalter the concentration of the oxidative stress marker 8-hydroxy-2'-deoxyguanosine in the culture\nsupernatant. Furthermore, Q-Media decreased the ratio of lactate production to glucose\nconsumption only slightly, and CoQ10 (232 μM) elevated intracellular Ca2+ concentration, as did\nATP (10 μM). These observations suggest that CoQ10 serves as a powerful aid in the production\nof MAbs by enhancing SPR without changing the character of cell growth, or adversely affecting\nquality or biological activity of MAbs.\nAntibody-dependent cellular cytotoxicity (ADCC) is dependent on the fucose content of\noligosaccharides bound to MAbs. As MAbs with a low fucose content exhibit high ADCC\nactivity, it is important to control the defucosylation levels (deFuc%) of MAbs and to analyze the\nfactors that affect deFuc%. In this study, we observed that the deFuc% was inversely related to\nculture medium osmolality for the MAbs produced in the YB2/0 cell line, with the r2 value as\nhigh as 0.92. Moreover, deFuc% exhibited the same correlation irrespective of the type of\ncompound used for regulating osmolality (NaCl, KCl, fucose, fructose, creatine, or mannitol) or\nculture scale (1–400 L). We succeeded in controlling MAb deFuc% by maintaining a constant\nmedium osmolality constant in both perfusion and fed-batch cultures. The regulation of medium\nosmolality with glucose is, however, sufficient for designing the deFuc% desired for efficacious\nADCC in YB2/0 cell culture. In agreement with these observations, real-time PCR analyses\nrevealed decreased transcription of genes involved in the glycolysis, GDP-fucose supply, and\nfucose transfer.\nIn this sutudy, both methods to enhance the efficiency of the production are achieved as an\nextension to existing processes. The present method to control deFuc% with medium osmolality\nwill open the way to use those mammalian cells, for glycoprotein production, that could not be\nemployed because of unwantedly high and/or uncontrollable fucose content in the\noligosaccharides attached to the protein. These findings will enable the use of the defucosylated\nIgG1 at lower doses with no reduction in efficacy without restart such as chainging the cell bank.
内容記述
内容記述タイプ Other
内容記述 学位記番号:工博甲428
書誌情報 p. 1-65, 発行日 2011-09-30
著者版フラグ
出版タイプ AM
出版タイプResource http://purl.org/coar/version/c_ab4af688f83e57aa
出版者
出版者 群馬大学工学研究科
資源タイプ
内容記述タイプ Other
内容記述 Thesis or Dissertation
学位名
学位名 博士(工学)
学位授与機関
学位授与機関名 群馬大学
学位授与年月日
学位授与年月日 2011-09-30
学位授与番号
学位授与番号 12301甲第428号
更新日
2019-12-05
戻る
0
views
See details
Views

Versions

Ver.1 2023-06-19 12:55:32.409470
Show All versions

Share

Mendeley Twitter Facebook Print Addthis

Cite as

エクスポート

OAI-PMH
  • OAI-PMH JPCOAR 2.0
  • OAI-PMH JPCOAR 1.0
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by WEKO3


Powered by WEKO3